| Objective: By conducting three glycolipids qing dynasty combined abdominal needle therapy obesity T2 DM clinical research,observation of patients with clinical symptoms,blood glucose levels,insulin resistance,6,and body weight index,improve further validate three glycolipids qing dynasty combined abdominal needle therapy effectiveness of obesity T2 DM,provide new ideas for clinical treatment of the disease,the new method.Methods:In this study,72 subjects who met the diagnostic criteria of obesity T2DM(spleen congestion,phlegm and blood stasis syndrome)were randomly divided into two groups,including 36 cases in the control group and 36 cases in the treatment group.Under the premise of diet and exercise control,the treatment group was given metformin hydrochloride tablet orally,Lingshu Tangzhi Qing prescription orally,and abdominal acupuncture treatment.The control group was given metformin hydrochloride tablets orally.4 weeks/course of treatment,a total of 3 courses.Before and after the trial,the total TCM syndrome score,body weight,BMI,abdominal circumference,islet function,blood glucose level and other data of the two groups of patients were recorded and compared,and the conclusions were drawn.Results:1.Analysis of the efficacy of TCM syndromes: the total effective rate of TCM syndromes in the treatment group was 91.17%,and the total effective rate of the control group was 78.12%,which was better in the treatment group than in the control group(P<0.05);2.Total scores of TCM syndromes: The total scores of TCM syndromes in the treatment group and the control group decreased significantly after treatment compared with before treatment(P<0.01).Compared with the control group,the total scores of TCM syndromes in the treatment group decreased more obviously(P<0.01).3.TCM symptom scores: after treatment,symptom scores of patients in the treatment group were significantly lower than before,with significant differences(P < 0.05);In the control group,nausea,vertigo and perspiration and sparse stool were not significantly improved after treatment(P > 0.05),and other scores were decreased with significant differences(P< 0.05).Compared with the control group,the scores of TCM symptoms were statistically significant(P < 0.05),indicating that the improvement of TCM symptom scores in the treatment group was better than that in the control group.4.The improvement of FPG,2HPG and HBALC in the treatment group was statistically significant compared with the control group before and after treatment(P < 0.05);Comparison between groups: the improvement of FPG,2HPG and HBALC in treatment group was better than that in control group(P < 0.05);5.The improvement of body weight,abdominal circumference and BMI between the treatment group and the control group was statistically significant compared with that before treatment(P < 0.05);Comparison between groups: the improvement of abdominal circumference,body weight and BMI in the treatment group was better than that in the control group(P < 0.05).6.Fasting insulin and insulin index:intra-group comparison showed that the fasting insulin and insulin index in the treatment group and the control group were significantly improved compared with before treatment,with statistical significance(P < 0.05).The fasting insulin and insulin resistance index in the treatment group were better than those in the control group(P < 0.05).7.Safety: 3patients developed obvious digestive tract symptoms during the experiment.Conclusion: lingya glycolipids qing dynasty combined abdominal needle therapy obesity T2DM(temper congestion,phlegm and blood stasis resistance winding certificate)curative effect,can effectively improve the clinical symptoms and signs,reduce blood sugar,improve insulin resistance,reduce weight,reduce 6 patients,treatment process has a good safety and operability,have clinical popularization and application value. |
